共 207 条
[1]
van Hagen P(2012)Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med. 366 2074-2084
[2]
Hulshof MC(2015)Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial Lancet Oncol. 16 1090-1098
[3]
van Lanschot JJ(2018)Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial J Clin Oncol. 36 2796-2803
[4]
Steyerberg EW(2006)Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden Ann Surg. 243 204-211
[5]
van Berge Henegouwen MI(2019)Benchmarking complications associated with esophagectomy Ann Surg. 269 291-298
[6]
Wijnhoven BP(2020)Lasting symptoms after esophageal resection (LASER): European multicenter cross-sectional study Ann Surg 15 2372-2379
[7]
Shapiro J(2008)The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: a systematic review Ann Surg Oncol. 98 1124-1131
[8]
van Lanschot JJB(2011)Discrete-choice preference comparison between patients and doctors for the surgical management of oesophagogastric cancer Br J Surg 95 592-601
[9]
Hulshof M(2008)Population-based study of surgical factors in relation to health-related quality of life after oesophageal cancer resection Br J Surg. 22 4202-4208
[10]
van Hagen P(2004)Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus J Clin Oncol. 36 268-275